New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For GNOM;ILMN From The Last 14 Days
Check below for free stories on GNOM;ILMN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
May 20, 2013
14:06 EDTILMNIllumina says Verinata reimbursements exceeding expectations
At the UBS Healthcare Conference earlier today, Illumina (ILMN) CFO Marc Stapley said adoption for the company's Verinata prenatal test has met expectations, while reimbursement for the test has exceeded expectations, adding that its relationship with PerkinElmer (PKI) has allowed the company to obtain significant coverage decisions. In afternoon trading, shares of Illumina are up $1.48, or 2.06%, to $73.48.
May 17, 2013
11:59 EDTILMNOptions with decreasing implied volatility: ILMN LO A HES INFY CSCO
11:39 EDTILMNHigh option volume stocks: GNK VNDA BYI ARUN BYI ILMN
Subscribe for More Information
May 15, 2013
17:26 EDTILMNThird Point gives quarterly update on stakes
NEW STAKES: Virgin Media (VMED), Tiffany (TIF), B/E Aerospace (BEAV), Anadarko (APC), and Thermo Fisher (TMO). INCREASED STAKES: International Paper (IP), Abbvie (ABBV), TransDigm (TDG), Constellation Brands (STZ), and Dollar General (DG). DECREASED STAKES: Delphi (DLPH), Murphy Oil (MUR), AIG (AIG), LyondellBasell (LYB), and Liberty Global (LBTYA). LIQUIDATED STAKES: Tesoro (TSO), Morgan Stanley (MS), Symantec (SYMC), Herbalife (HLF), and Illumina (ILMN).
06:36 EDTILMNIllumina to partner for automation of sample preparation kits
Subscribe for More Information
May 14, 2013
10:24 EDTILMNIllumina management to meet with JPMorgan
Subscribe for More Information
May 10, 2013
15:59 EDTILMNRoche spokesman reiterates that Illumina is "off the table," Bloomberg reports
Subscribe for More Information
15:07 EDTILMNIllumina calls active on renewed takeover speculation
Subscribe for More Information
14:59 EDTILMNRumor: Illumina strength attributed to takeover speculation

Sign up for a free trial to see the rest of the stories you've been missing.